In my mind the issue of whether or not the roll out is progressing too slowly is as yet undecided. As you are aware, one of the objectives of the commercialization phase was to place the devices in the hands of opinion makers in the Dermatology community. While I cannot speak for the rest of the country, my checking here in NY indicates that they are very successful in that respect. It is also my opinion that because of all the difficulty with the FDA approval they are moving very carefully to insure that the installations are utilizing the equipment under the dictates of the FDA. In a nutshell, it is still to early to discuss sale of the company or a partnership.